saplin

PGIM India Healthcare Fund

PGIM India Healthcare Fund (Direct, Growth): saplin Score 6.7/10 (Neutral) among 14 Sectoral/Thematic funds. 1Y return 26.9%, expense ratio 0.98%. Returns that beat most peers, but a short or weak manager record. NAV ₹12.87 on 11 Nov 2026.

Loading the full analysis…

Questions about PGIM India Healthcare Fund

What is the expense ratio of PGIM India Healthcare Fund?

The Direct plan's total expense ratio is 0.98% a year, against a median of 1.04% for sectoral/thematic funds. The Regular plan costs more because it pays a distributor's commission.

Who manages PGIM India Healthcare Fund?

Anandha Padmanabhan Anjeneyan (since 6 Dec 2024); Utsav Mehta (since 6 Dec 2024); Vivek Sharma (since 6 Dec 2024); Puneet Pal (since 6 Dec 2024).

What are the top holdings of PGIM India Healthcare Fund?

Divi's Laboratories 11.08%, Sun Pharmaceutical Industries 10.47%, Torrent Pharmaceuticals 8.34%, Ajanta Pharma 5.16%, Dr. Lal Path Labs 4.34% of the portfolio, as of 31 Oct 2026.

What returns has PGIM India Healthcare Fund given?

1 year: 26.9% (category median 21.9%). Past returns do not predict future ones.

How big is PGIM India Healthcare Fund?

About ₹118 cr (AMFI's average for the latest quarter).

How does PGIM India Healthcare Fund score?

6.7 out of 10 (Neutral) on the saplin Score, which rates a fund against its own category on returns, risk, consistency, cost and its manager. See the methodology for how it is worked out.